Lmr Partners LLP Curis Inc Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $410,651 - $896,818	-55,121 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $483,962 - $705,548	55,121 New	55,121 $624,000
Q3 2018 Nov 14, 2018	SELL	$1.38 - $1.94 $98,625 - $138,647	-71,468 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$1.73 - $3.35 $123,639 - $239,417	71,468 New	71,468 $124,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.